Clinical trials: Chemotherapy-Induced Change
High-Grade Lymphomas
HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy
The study is planned to compare the outcome of aggressive NHL patients in partial remission after four courses of front-line therapy, randomly assigned to receive either additional four courses of the same regimen or a modified…
- Trial name
- NCT00866203
- Testing
- HDS vs ProMECE/CytaBOM
- Where
- Italy
- Volunteers
- 441 people
- Sponsor
- Gruppo Italiano Studio Linfomi
Drug/Agent Toxicity by Tissue/Organ, Unspecified Adult Solid Tumor, Protocol Specific
Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Chemoprotective drugs, such as amifostine, may protect normal cells from the side effects of chemotherapy.
- Trial name
- NCT00003252
- Testing
- amifostine trihydrate
- Where
- United States
- Sponsor
- Rush North Shore Medical Center